Skip to main content

Table 3 Blood loss, length of hospital stay and complications after total knee arthroplasty

From: Bridging therapy for oral anticoagulation increases the risk for bleeding-related complications in total joint arthroplasty

 

UFH bridging

LMWH bridging

LMWH prophylaxis

p value

(n = 4)

(n = 8)

(n = 1000)

Blood loss

    

 Preop. haemoglobin level, mmol/L (range)

8.5 (8.0–9.2)

8.6 (7.6–10.3)

8.5 (6.2–10.9)a

0.902

 Postop. haemoglobin level, mmol/L (range)

5.6 (4.9–6.0)

6.4 (5.0–9.0)

6.5 (4.0–9.9)b

0.104

 Haemoglobin decrease, mmol/L (range)

3.0 (2.1–3.9)

2.2 (1.3–4.2)

2.0 (0.2–4.8)c

0.012

 Transfusion units

n (range)

0.5 (0–2)

0 (0)

0.15 (0–9)

0.449

 

Median

0.0

0.0

0.0

 

 Bleeding index

Mean (range)

3.5 (2.1–5.9)

2.2 (1.3–4.2)

2.1 (0.2–12.4)c

0.045

 

Median

2.9

1.9

2.0

 

Hospital stay

    
 

Mean days (range)

32.5 (12–83)

9.6 (5–20)

7.4 (4–112)

0.552

 

Median

17.5

8.5

7

 

Complications

    

 Any complication

3 (75 %)

5 (63 %)

156 (15.6 %)

<0.001

 Bleeding-related complication

    

  Major bleeding

1 (25 %)

1 (13 %)

26 (2.6 %)

0.041

  Minor bleeding

2 (50 %)

1 (13 %)

5 (0.5 %)

<0.001

  Neuropraxia due to hematoma

0

0

0

NAd

  Evacuation of hematoma

0

0

1 (0.1 %)

NAd

 Thromboembolic complication

    

  Arterial thromboembolism

0

0

9 (0.9 %)

1.000

  Deep venous thrombosis

0

0

13 (1.3 %)

1.000

  Pulmonary embolism

0

0

5 (0.5 %)

1.000

 Heparin-induced thrombocytopenia

0

0

0

NAd

 Infected TKA

1 (25 %)

1 (13 %)

8 (0.8 %)

0.006

 Death

0

0

4 (0.4 %)

1.000

  1. aTwenty-two values unknown
  2. bThree values unknown
  3. cTwenty-five values cannot be calculated
  4. dNot applicable, number too small to perform statistics